RAC1 and melanoma: In B16-F10 melanoma cells, both Rac1 transfection and CT04 treatment reduced the percentages of cells in early and late apoptosis to 2.8% and 3.8%, for Rac1-transfected cells, and to 4.3% and 2.9%, for CT04-treated cells, respectively (Figure 4C, D).